Selective surgical excision of high-risk lesions

Surgery. 2023 Jul;174(1):125-128. doi: 10.1016/j.surg.2023.02.028. Epub 2023 Apr 12.

Abstract

Intraductal papilloma, flat epithelial atypia, radial scar, atypical lobular hyperplasia, and lobular carcinoma in situ have historically been referred to as high-risk lesions and managed with routine surgical excision after diagnosis on core needle biopsy. The misnomer high-risk stems from high rates of upgrade to malignancy reported in historic literature. However, recent studies have found much lower upgrade rates, <2%, than previously thought. These findings are explained by advances in imaging technology, larger-bore biopsy needles, and emphasis on radiology-pathology concordance. Concordant lesions have a low upgrade risk and can be managed with radiographic and clinical surveillance instead of surgical excision. Surgical de-escalation is feasible for many of these lesions with careful multidisciplinary review and a detailed risk-benefit discussion with patients.

MeSH terms

  • Biopsy, Large-Core Needle
  • Breast Neoplasms* / pathology
  • Carcinoma, Intraductal, Noninfiltrating* / surgery
  • Female
  • Humans
  • Hyperplasia
  • Radiography
  • Retrospective Studies
  • Risk